Despite the availability of multiple evaluation indices, the current assessment framework for AD severity is heterogeneous and highly dependent on subjective judgment, leading to considerable inter-individual variability. As a result, objective criteria for disease stratification and timely therapeutic intervention are lacking. we focused on proteins involved in two key biological processes closely associated with AD pathogenesis: metabolism and inflammation.